NEUROCRINE BIOSCIENCES INC (NBIX) Gross margin 2016–2025
NEUROCRINE BIOSCIENCES INC (NBIX) gross margin by fiscal year — reported gross profit divided by reported revenue.
98.2%FY2025 · since FY2016: 100.0% → 98.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 98.2% | -0.4 pp |
| FY2024 | 98.6% | +0.7 pp |
| FY2023 | 97.9% | -0.5 pp |
| FY2022 | 98.4% | -0.3 pp |
| FY2021 | 98.7% | -0.3 pp |
| FY2020 | 99.0% | — |
| FY2018 | 98.9% | -0.3 pp |
| FY2017 | 99.2% | -0.8 pp |
| FY2016 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice